Nephrotic Syndrome

Knowledge Check

Exam-style MCQs aligned with these notes. Available to Hyperexcision Scholar members.

Log in to access
Last updated: June 19, 2026Bookmark

Nephrotic syndrome occurs when the glomerular basement membrane and podocytes are damaged. It is characterised by:

  • Massive proteinuria of > 3g/24 hours (P:CR > 300 mg/mmol, A:Cr > 250 mg/mmol). In children, 40 mg per square meter body surface area per hour.
  • Hypoalbuminemia with plasma albumin < 3.0 g/dL.
  • Peripheral edema
  • Hyperlipidemia and lipiduria

The causes of nephrotic syndrome can be broadly classified into primary causes, which encompass diseases that are intrinsic to the kidney, and secondary causes, which are systemic in nature.

CategoryCauses
Primary causesMembranous nephropathy, minimal change disease, focal segmental glomerulosclerosis (FSGS), membranoproliferative glomerulonephritis (MPGN)
Secondary causesDiabetic nephropathy, lupus nephritis (SLE), sjorgen’s syndorme, pre-eclampsia, multiple myeloma, amyloid nephropathy, medications (NSAIDS, penicillin, captopril, gold salts), congenital nephritic syndrome (defective nephrin)
Infectious causesHepatitis B, HIV, syphillis, hepatitis C
  • Pathophysiology
    • The main event leading to nephrotic syndrome is structural damage of the glomerular filtration barrierby the following mechanisms:
      • Deposition of circulating immune complexes in the glomerulus
      • Antibody deposition in the glomerulus which react with endogenous glomerular antigens or planted (foreign) antigens
      • Systemic diseases such as systemic lupus nephritis, hypertension and diabetes mellitus
    • This leads to loss of the structural integrity and negative charge of the glomerular filtration barriercausing an abnormal loss of protein which causes a compensatory increase in hepatic protein synthesis.
    • For a while this bridges the gap in protein loss but when loss exceeds the capacity for compensation the following occurs:
      • Low albumin levels: leading to reduced colloid osmotic pressure hence a shift of fluid into the interstitium causing edema
      • Loss of antithrombin, proteins C and S – these are clotting inhibitors hence their loss leads to a hypercoagulable state increasing the risk of thrombosis
      • Loss of thyroglobulin – this is a protein responsible for transporting thyroxine hence its loss causes hypothyroidism as thyroxine cannot be moved around the body
      • Loss of Vitamin D binding proteins – leading to reduced levels of Vitamin D and concurrent reduced calcium absorption – hypocalcemia
      • Loss of plasma proteins – leading to reduced drug binding hence increased free drug concentrations
      • Loss of immunoglobulins – causing an increased risk of infection
      • Loss of transferrin – leading to reduced iron levels as iron is transported by transferrin
    • To compensate for reduced intravascular oncotic pressure due to low plasma protein levels (particularly albumin) the liver increases production of cholesterol, triglycerides and lipoproteins causing hyperlipidaemia and lipiduria.
    • Due to the shift of fluid from the intravascular space into the interstitium, hypovolemia occurs stimulating the renin-angiotensin-aldosterone system (RAAS) and antidiuretic hormone secretion.
    • This causes increased reabsorption of sodium and water in the renal tubules so as to restore intravascular volume.
    • Sodium retention causes hypertension and exacerbates edema due to increased water reabsorption
  • Signs and symptoms
    • Edema
      • Facial edema (first sign of nephrotic syndrome in children )
      • Dependent edema (presents in adults)
      • Generalized edema (presents over time as increasing weight, ascites, pleural and pericardial effusion)
    • Frothy urine – due to lipiduria
    • Hypertension – due to sodium retention (in some cases)
    • Frequent infections – meningococcal and pneumococcal infections
    • Symptoms of hypocalcemia such as tetany, muscle spasms and paraesthesia
    • Symptoms of hypocalcemia such as tetany, muscle spasm and paraesthesia
    • Increased risk of clotting
    • Other symptoms of underlying disease
  • Investigations
    • Urinalysis
      • Nephrotic-range proteinuria will be apparent by 3+ or 4+ readings
      • Casts
      • Glycosuria (diabetes)
    • 24 hour urine protein can be done for an accurate measure of proteinuria
    • Protein:Creatinine ratio (P:CR) using a spot sample of urine (first morning urine sample)
      • 300 mg/mmol (3 mg/mg) confirms nephrotic range proteinuria
    • UECs
      • Raised serum creatinine (>4 mg/dL indicates seriously impaired renal function)
    • Serum albumin
      • Less than the normal range of 3.5 to 4.5 g/dL
    • Lipid profile
      • Total cholesterol and triglyceride levels are typically increased
    • Hepatitis B and C serolgy
    • HIV testing
    • Syphilis
    • Antinuclear antibody (ANA)
    • Anti–double stranded DNA (anti-dsDNA) antibodies
    • C3 and C4 omplement
    • HBA1c
    • Random blood sugar testing
    • Serum or urine protein electrophoresis
    • KUB ultrasound is done to ensure the patient has two kidneys, since having only one increases the risk of developing focal glomerulosclerosis and is a contraindication for renal biopsy
      • Increased renal echogenicity is consistent with intrarenal fibrosis.
    • Renal biopsy
    • Phospholipase A Receptor (PLA R) antibodies: PLA R is a transmembrane receptor found on podocytes. Autoantibodies targeting this receptor have been found in 70% of idiopathic membranous nephropathy cases.
      • There is a strong correlation between levels of this antibody and clinical disease activity. Therefore it helps in monitoring disease activity and treatment efficiency.
  • Indications for renal biopsy
    • Congenital nephrotic syndrome
    • Age older than 8 years at onset
    • Steroid resistance
    • Frequent relapses or steroid dependency
    • Significant nephritic manifestations
    • Adult nephrotic syndrome of unknown origin
  • Treatment
    • For oedema:
      • Dietary sodium restriction
      • Dietary protein restriction
      • Fluid restriction <1.5 L a day
      • Loop diuretics – high-dose furosemide or torsemide
      • Other diuretics e.g. oral thiazide or spironolactone can be used
      • Furosemide binds to albumin but due to reduced albumin levels, there will be decreased delivery of the drug to the kidney. Albuminuria will increase binding of the drug in the tubular lumen causing it to be lost in urine. For this reason, furosemide is given in high doses.
      • Albumin can be considered since it is difficult to achieve satisfactory diuresis, especially if the serum albumin level is less than 1.5 g/dL.
    • Statins for hyperlipidemia
    • RAAS inhibitors (ACE inhibitors and ARBs)
      • Reduce proteinuria
      • Treats hypertension secondary to sodium retention
    • For adults:
      • Corticosteroids (prednisone) combined with cylcophosphamide/tacrolimus/cyclosporin can achieve remission
      • Treatment of underlying disease, e.g, strict glycemic control in diabetic patients
    • For children:
      • Corticosteroids are mainly used for idiopathic nephrotic syndrome.
      • Cyclophosphamide, mycophenlate, calcineurin inhibitors, or rituximab can be used in cases with frequent relapse, steroid dependency or steroid resistance
      • Penicillin can be started in children with overt edema
      • Treat bacterial infections promptly
      • Routine immunizations (Pneumococcal and influenza vaccinations) should be deferred until there are no relapses and the patient has been off immunosuppressants for at least three months.
  • Complications
    • Infection
    • Hypocalcemia and bone abnormalities
    • Hyperlipidemia and atherosclerosis increasing the risk for cardiovascular disease
    • Hypercoagulability
    • Hypovolemia
    • Hypertension due to reduced kidney function and fluid retention
    • Edema of the gut could cause defective absorption resulting in malnutrition
    • Ascites and pleural effusions
    • Generalized edema
    • Respiratory distress
    • Sepsis
    • Peritonitis
    • Thromboembolism
    • Failure to thrive
    • Urinary loss of hormone binding proteins such as thyroxine binding globulin thus causing reduced low hormone levels
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Leave a Reply

A moment of your time
Step 1 of 2

You are the reason this exists. Got 60 seconds? Help us improve Hyperexcision for every medical student who uses it.

The Hyperexcision Team